GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Theranexus (XPAR:ALTHX) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 24, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Theranexus Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Theranexus's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Theranexus's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Theranexus's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theranexus's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theranexus's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Theranexus's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Theranexus  (XPAR:ALTHX) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Theranexus Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Theranexus's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Theranexus Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theranexus SA (XPAR:ALTHX) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XPAR:ALBPS XPAR:ALINT XPAR:ALMDP XPAR:ALTME XPAR:ALNEV XPAR:ALOPM XPAR:ALTAO XPAR:ALVIO XPAR:ALPAT XPAR:ALNFL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
3VG:Germany
Address
60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008
Website
https://www.theranexus.com
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

Theranexus Headlines

No Headlines